遗传性痉挛性截瘫15型表现为青少年起病左旋多巴反应性帕金森综合征
一例27岁男性,12岁起病,表现为言语延迟和慢性进展性运动障碍,初期有运动迟缓和静止性震颤,口服左旋多巴一度改善症状,但2年后出现运动波动和异动症。基因检测先后发现PRKN基因杂合致病性变异和ZFYVE26基因致病变异,最终诊断为遗传性痉挛性截瘫15型(SPG15)。该病例提示青少年起病帕金森综合征需全面基因分析以明确诊断。
要点
- 青少年起病帕金森综合征伴左旋多巴反应需警惕遗传性痉挛性截瘫等遗传病。
- SPG15可表现为帕金森综合征,常伴认知障碍、言语延迟和下肢痉挛。
- 对左旋多巴反应进行性丧失或出现非典型体征时,应重新评估并完善基因检测。
核心结论
- SPG15可表现为青少年起病的左旋多巴反应性帕金森综合征,全面基因分析有助于鉴别诊断。
研究设计与样本
- 单例病例报告:27岁男性,12岁起病,随访7年,接受基因检测、脑MRI及多种治疗。
主要发现
- 患者初期口服左旋多巴改善症状,2年后出现运动波动和异动症。
- 脑MRI显示胼胝体变薄,基因检测先后发现PRKN基因杂合致病性变异和ZFYVE26基因致病变异。
- 随病程进展对口服及持续左旋多巴-卡比多巴肠凝胶输注反应进行性丧失。
- 脑深部电刺激和肉毒毒素注射疗效有限。
临床怎么用
- 青少年起病帕金森综合征应详细评估痉挛、认知及言语延迟等非典型体征。
- 对左旋多巴反应进行性下降或出现异动症时,应考虑遗传性痉挛性截瘫等鉴别诊断。
- 全面基因检测有助于明确基因型-表型关联并指导治疗。
局限性
- 单例病例报告,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report the case of a 27-year-old man with a history of speech delay and chronic, progressive movement disorder. He first developed gait difficulty at the age of 12. Given clinical signs of bradykinesia and resting tremor, he received a clinical diagnosis of childhood-onset parkinsonism. Treatment with oral levodopa initially improved symptoms, but after 2 years, he developed motor fluctuations and dyskinesias. Additional signs of spasticity and brain MRI showing a thin corpus callosum prompted genetic testing that identified a heterozygous pathogenic variant in the PRKN gene. However, he exhibited a progressive loss of response to chronic dopaminergic therapy, first with oral and later with continuous levodopa-carbidopa intestinal gel infusion, with disease progression over 7 years. This progression led to further genetic testing and the diagnosis of hereditary spastic paraplegia type 15 (SPG 15). Advancing motor symptoms prompted deep brain stimulation and botulinum toxin injections, although these had limited benefit. This case highlights the challenges of diagnosing and managing juvenile-onset parkinsonism and the value of comprehensive genetic analysis in evaluating genotypic-phenotypic correlations. Hereditary spastic paraplegias (HSPs) are a rare group of neurodegenerative disorders with diverse clinical and genetic features. They can be inherited in autosomal dominant, recessive, X-linked, or mitochondrial patterns. The SPG15 subtype (or HSP-ZFYVE26), caused by pathogenic variants in the ZFYVE26 gene, is a common form of autosomal recessive HSP. Presenting symptoms vary but commonly include cognitive impairment with a history of speech delay or learning disability and balance impairment or clumsiness from spasticity of the lower limbs.
引用
- Thatikala A, Boddu AV, Nayar D, et al. Pearls & Oy-sters: Hereditary Spastic Paraplegia Type 15 Presenting as Juvenile Onset Levodopa-Responsive Parkinsonism. Neurology. 2026. PMID: 41505685. doi:10.1212/WNL.0000000000214514
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。